Colgate-Palmolive Company (CL) Reiterated at Buy by UBS: Aiming for Top-Line Organic Growth
August 21, 2026 8:37 AM
UBS analyst Peter Grom reiterated a Buy rating and $109.00 price target on Colgate-Palmolive Company (NYSE: CL).The analyst commented, "Management's ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
